ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,378,121 | -32.8% | 110,830 | -35.9% | 0.00% | -33.3% |
| Q2 2023 | $15,434,360 | -53.6% | 172,934 | -44.3% | 0.00% | -57.1% |
| Q1 2023 | $33,281,088 | +33.8% | 310,400 | +52.4% | 0.01% | +16.7% |
| Q4 2022 | $24,875,561 | +181.2% | 203,681 | +137.8% | 0.01% | +200.0% |
| Q3 2022 | $8,846,000 | -13.9% | 85,662 | -22.5% | 0.00% | 0.0% |
| Q2 2022 | $10,272,000 | -56.9% | 110,500 | -45.6% | 0.00% | -60.0% |
| Q1 2022 | $23,823,000 | +20.6% | 202,987 | +38.3% | 0.01% | – |
| Q4 2021 | $19,746,000 | +49.1% | 146,790 | +76.7% | 0.00% | -100.0% |
| Q3 2021 | $13,241,000 | -24.1% | 83,075 | -37.4% | 0.00% | 0.0% |
| Q2 2021 | $17,446,000 | +65.6% | 132,618 | +62.3% | 0.00% | 0.0% |
| Q1 2021 | $10,532,000 | -18.3% | 81,726 | +5.8% | 0.00% | – |
| Q4 2020 | $12,888,000 | -6.7% | 77,268 | -13.7% | 0.00% | -100.0% |
| Q3 2020 | $13,813,000 | -59.6% | 89,507 | -61.3% | 0.00% | -62.5% |
| Q2 2020 | $34,163,000 | +43.9% | 230,987 | +9.5% | 0.01% | 0.0% |
| Q1 2020 | $23,748,000 | -66.1% | 210,888 | -58.2% | 0.01% | -60.0% |
| Q4 2019 | $70,111,000 | -3.5% | 503,961 | -33.2% | 0.02% | -20.0% |
| Q3 2019 | $72,637,000 | -67.8% | 754,123 | -61.5% | 0.02% | -10.7% |
| Q2 2019 | $225,843,000 | +109.3% | 1,961,306 | +114.0% | 0.03% | -36.4% |
| Q1 2019 | $107,883,000 | +256.9% | 916,600 | +90.0% | 0.04% | +266.7% |
| Q4 2018 | $30,229,000 | +86.7% | 482,500 | +111.2% | 0.01% | +140.0% |
| Q3 2018 | $16,188,000 | -20.2% | 228,442 | -25.1% | 0.01% | -28.6% |
| Q2 2018 | $20,285,000 | – | 304,945 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,225,357 | $1,001,863,112 | 18.92% |
| Q Global Advisors, LLC | 195,000 | $17,404 | 12.55% |
| Sofinnova Investments, Inc. | 754,032 | $67,297,356 | 4.41% |
| Avoro Capital Advisors LLC | 3,580,555 | $319,564,534 | 4.34% |
| Finepoint Capital LP | 139,772 | $12,474,651 | 4.32% |
| Spyglass Capital Management LLC | 657,853 | $58,713,380 | 4.24% |
| Saturn V Capital Management LP | 78,442 | $7,000,948 | 3.88% |
| DAFNA Capital Management LLC | 135,212 | $12,067,671 | 3.30% |
| ARS Investment Partners, LLC | 289,860 | $25,870,005 | 3.02% |
| Ghost Tree Capital, LLC | 100,000 | $8,925,000 | 2.95% |